Why researchers are hopeful that photonic lithotripsy, an innovative approach to fragmenting kidney stones, could be an alternative for patients who don’t succeed with current interventions.
Read MoreAssessing the Role of Alloreactive CD28– Memory CD8 T Cells in Allograft Injury
Acute allograft injury is a significant factor in late graft loss following kidney transplantation. Cleveland Clinic research into the function of alloreactive CD28- memory CD8 T cells should help in the assessment of rejection and graft injury risk.
Partial Nephrectomy Versus Radical Nephrectomy: Where Do We Stand in 2014?
Why do nephrologists feel so strongly about avoiding radical nephrectomy? Recent data suggest that the renal functional advantage of partial nephrectomy over radical nephrectomy in the setting of a normal contralateral kidney may not be as beneficial as previously believed.
Does Radiation Treatment for Prostate Cancer Heighten MDS Risk?
Radiation treatment for prostate cancer inadvertently irradiates the surrounding pelvic bones, which hold more than half the body’s active bone marrow mass. But a Cleveland Clinic study finds that men who undergo the procedure have no greater risk of developing myelodysplastic syndromes than the general population.
MP-MRI-US Fusion Targeted Biopsy: A Promising New Diagnostic Tool for Prostate Cancer
Specialized software now combines multiparametric MRI and transrectal ultrasound images to improve targeted biopsy of suspicious lesions. The technology has the potential to significantly improve localization and characterization of prostate cancer when added to a 12-core biopsy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Researchers Find Mutation That Promotes Hormone Therapy Resistance
Cleveland Clinic researchers have discovered the first example of a genetic alteration that increases the conversion of precursor steroids to 5α-dihydrotestosterone (DHT), permitting prostate tumors to grow in the absence of gonadal testosterone.
Recent Research Highlights Treatment Options for Resistant Hypertension Patients
A trial studying renal denervation for resistant hypertension and a new Resistant Hypertension Clinic are advancing understanding of this condition.
Making a Case for Tubeless Percutaneous Nephrolithotomy
Tubeless percutaneous nephrolithotomy is effective and safe regardless of intraoperative issues that were previously used as exclusionary criteria for this approach.
Gene Signature Test Accurately Predicts Individual Clinical Outcomes in Prostate Cancer Patients
Results help identify active surveillance candidates
New Nephrology Department Chairman Appointed
After a national search, Cleveland Clinic’s Board of Governors has chosen Robert Heyka, MD, a 27-year veteran of the institution’s medical staff, as Chair of the Department of Nephrology and Hypertension.